Target intelligence / Profile preview

Keratin (nail) and fungal cell wall structures

Molecular classification
Keratin: Intermediate filament protein, Fungal cell wall: Structural polysaccharide/protein complex (mainly chitin, β-glucans, mannans, glycoproteins)
01

Overview

Nail keratin is a structural protein forming the main component of the nail plate, providing rigidity and mechanical protection. It is highly cross-linked by disulfide bonds, making it insoluble and resistant to proteolytic enzymes, which contributes to the formidable barrier property of the nail. Fungal cell structures, particularly the cell wall, are composed of chitin, β-glucans, mannans, and other glycoproteins that provide both structural integrity and dynamic adaptability, and are essential for fungal growth, morphogenesis, and pathogenicity. In onychomycosis, dermatophyte fungi (such as Trichophyton species) invade the keratinized nail plate; their ability to digest keratin and remodel their cell walls plays a central role in infection and virulence. Treatments target fungal cell wall biosynthesis and attempt to overcome the nail's barrier properties to deliver drugs effectively. However, this functional designation ("Nail Keratin and Fungal Cell Structures") is not a single molecular target but rather describes relevant host and pathogen biology in fungal nail disease. Critical note: This entry does not refer to a conventional drug target in the sense of molecular pharmacology but rather an anatomical and pathogen structure relevant to disease mechanism and therapy resistance.

Other names
nail keratinnail structural proteinsfungal cell wallfungal cell wall polysaccharidesonychomycosis target
02

Mechanism of action

Antifungals: Inhibit fungal cell wall synthesis, disrupt fungal membrane synthesis, or increase nail plate permeability to enable drug access

03

Biological functions

Keratin: Mechanical protection, structural integrity of nailFungal cell wall: Cell integrity, morphogenesis, protection, virulence
04

Disease associations

Infection (specifically fungal infections of the nail, i.e., onychomycosis)Barrier in antifungal drug delivery (therapeutic challenge)
05

Safety considerations

Slow nail growth and poor drug penetration limit treatment efficacy; fungal resistance may developMinimal systemic safety concerns when topical, but oral antifungal agents (e.g., terbinafine, itraconazole) have hepatotoxicity risk
06

Interacting drugs

For keratin as a barrier: Topical antifungals (e.g., ciclopirox, amorolfine, efinaconazole, tavaborole)

1 more in the full profile.

Beyond the preview

Go deeper on Keratin (nail) and fungal cell wall structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin (nail) and fungal cell wall structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call